Stephen Biggar
Chairman at ACADIA PHARMACEUTICALS INC.
Net worth: 88 050 $ as of 29/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen Davis | M | 63 | 13 years | |
Sanj Patel | M | 54 | 16 years | |
Felix Baker | M | 55 | 24 years | |
Gavin MacBeath | M | 54 | 6 years | |
R. Woods | M | 57 | 1 years | |
Rachel McMinn | M | 51 | 6 years | |
Eben Tessari | M | 42 | 10 years | |
Thomas Malley | M | 55 | 18 years | |
Barry Quart | M | 67 | 12 years | |
Timothy Barberich | M | 76 | 5 years | |
Michael Megna | M | 53 | 6 years | |
Jon Stonehouse | M | 63 | 17 years | |
Mark Ragosa | M | 50 | 6 years | |
George Abercrombie | M | 69 | 13 years | |
Katina Dorton | F | 66 | 3 years | |
Bob Mischler | M | - | 9 years | |
Tracey McCain | F | 56 | 6 years | |
Cory Freedland | M | 48 | 1 years | |
Peter Zandstra | M | - |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 6 years |
Melissa Manno | F | - | 9 years | |
Mark Schneyer | M | 50 | 4 years | |
Zoran Zdraveski | M | 54 | 3 years | |
Rachel Frank | F | - | - | |
Julian Baker | M | 57 | 9 years | |
Elizabeth Garofalo | M | 66 | 4 years | |
Brendan Teehan | M | 56 | 6 years | |
Gabriela Gruia | M | 67 | 3 years | |
Madelyn Zeylikman | F | - | 4 years | |
Julie Fisher | F | - | 6 years | |
Leiden Dworak | M | - | 2 years | |
Albert Kildani | M | - | 1 years | |
Barbara Klencke | M | 66 | 1 years | |
Sarah Noonberg | M | 56 | 1 years | |
William P. Sheridan | M | 69 | 16 years | |
Edmund Harrigan | M | 71 | 9 years | |
Rohan Palekar | M | 58 | 1 years | |
Jennifer J. Rhodes | F | 53 | - | |
David Main | M | 59 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | 4 years |
Robert Baffi | M | 68 | 1 years | |
Richard Levy | M | 66 | 5 years | |
Don Soland | M | 65 | 9 years | |
Kim Popovits | F | 65 | 6 years | |
Christine Cvijic | F | 46 | 1 years | |
Laura Brege | F | 66 | 16 years | |
G. Cole | M | 68 | 4 years | |
James Daly | M | 63 | 8 years | |
Alane Barnes | F | 58 | 18 years | |
Katherine Bishop | M | 58 | 3 years | |
Ray Lockard | M | - | 1 years | |
Benir Ruano | M | - | 2 years | |
Rob Ackles | M | - | 10 years | |
Ricardo Jimenez | M | - | - | |
Julie Jordan | M | - | - | |
Shrikanta Chattopadhya | M | - | - | |
Kazenelson Deb | F | - | - | |
Ann Hargraves | F | - | 4 years | |
Donna Cochener-Metcalfe | F | 49 | - | |
Timothy Penner | M | 68 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
Adora Ndu | M | 43 | 2 years | |
John Paolini | M | 59 | 8 years | |
Raf Hofstein | M | 74 |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | - |
Andrew E. Mulberg | M | - | - | |
Jason Amello | M | 55 | - | |
Arvind Sreedharan | M | - | - | |
Parag V. Meswani | M | - | 2 years | |
Martina Struck | M | - | 6 years | |
Stuart Cobb | M | 54 | 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Christopher Heberlig | M | 49 | 12 years | |
Thomas Beetham | M | 55 | 8 years | |
Christoph H. Westphal | M | 56 | 3 years | |
Thomas H. Aasen | M | 63 | 16 years | |
Brian Silver | M | 55 | 2 years | |
Uli Alf Hacksell | M | 74 | 15 years | |
Thomas Staab | M | 56 | 9 years | |
Stephen Mahoney | M | 53 | 7 years | |
Elena Ridloff | F | 44 | 3 years | |
Rasmus Holm-Jorgensen | M | 53 | 11 years | |
Michael A. Darwin | M | 62 | 8 years | |
David Southwell | M | 63 | 5 years | |
Carsten Boess | M | 57 | 9 years | |
Michael T. Borer | M | 65 | 11 years | |
Glenn F. Baity | M | 54 | 14 years | |
Amanda Morgan | F | - | - | |
Michael Jones | M | 54 | 13 years | |
Brendan Classon | M | - | - | |
Robert S. Lowrey | M | 63 | 2 years | |
Mary Gray | M | 71 | 11 years | |
James A. Nash | M | 73 | - | |
Mark Goldberg | M | 69 | 6 years | |
Ittai Harel | M | 56 | 4 years | |
Leslie L. Iversen | M | 86 | 18 years | |
Torsten Erik Rasmussen | M | 78 | 17 years | |
William James Alexander | M | 74 | - | |
Stanley Erck | M | 76 | 10 years | |
Charles E. Bugg | M | 82 | 21 years | |
Les Kaplan | M | 73 | 18 years | |
Kenneth Lee | M | 76 | 12 years | |
Peder K. Jensen | M | 69 | 4 years | |
William McDowall Wells | M | 63 | 4 years | |
Charlie Sanders | M | 91 | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 84 | 84.00% |
Canada | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Biggar
- Personal Network